Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bormioli Pharma to Acquire GCL Pharma for €8.9M | Contract Pharma

What are you searching for?

Sign in
Breaking News

Bormioli Pharma to Acquire GCL Pharma for €8.9M

Expands industrial footprint by adding new technologies to extend its oral and parenteral product range

By: Tiffany Coppolino

Bormioli Pharma, a producer of pharmaceutical glass and plastic primary packaging, has entered an agreement to acquire GCL Pharma, an Italian subsidiary of the Guala Closures Group, specialized in the production of plastic, rubber and aluminum closures for pharmaceutical applications. The transaction, valued at €8.9 million, is expected to close in the next few weeks.
 
This follows Bormioli’s acquisition of Remy & Geiser completed last Fall, expanding its product range and ability to support the most demanding pharmaceutical needs.
 
In 2019 GCL Pharma recorded revenue of approximately €8 million. Over the years, the company has grown its capabilities and improved its product range to meet stringent pharma standards. The company’s main premises and production plant are located in Vasto (Chieti). 
 
“With the acquisition of GCL Pharma, we will continue our growth path,” said Andrea Lodetti, CEO of Bormioli Pharma. “We aim to strengthen our industrial footprint by adding new technologies that allow us to extend our product range, especially in the oral and parenteral segments, further activating our business synergies.”
 
 
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics